Value Investing

David Goodboy's picture
3 Good Stocks To Buy Under $5

These gains are homegrown right here in the United States and can be had for less than the cost of your morning coffee.

by David Goodboy | May 10, 2017
Joseph Hogue's picture
3 Value Plays In The Market’s Most Expensive Sector

These solid stocks will allow investors to participate in potential growth and should provide protection from downside risks.

by Joseph Hogue | April 05, 2017
Richard Robinson's picture
This Toolmaker Is At Least 30 Percent Undervalued

This often overlooked company boasts steady cash flows and long-term growth -- a safe bet in a market of risky stocks.

by Richard Robinson | March 27, 2017
Adam Fischbaum's picture
2 True Growth Stories In An Unexpected Sector

Both are trading at a discount to market averages and previous highs -- but the next year could deliver additional 20% gains above those levels.

by Adam Fischbaum | February 24, 2017
Michael Vodicka's picture
8 Value Buys In The S&P 500

It would be easy to look at the S&P 500's high P/E ratio as an obstacle, but it's actually an opportunity.

by Michael Vodicka | February 01, 2017
Brad Briggs's picture
How To Invest In The Trump Era

Trump's administration will have profound impacts on American economy and business, and this sector in particular is set to soar.

by Brad Briggs | January 25, 2017
Adam Fischbaum's picture
Make An Easy 12 Percent On This Mall Stock

Even as the retail sector falters, you can count on this company's able management to deliver market-beating returns.

by Adam Fischbaum | January 17, 2017
Nathan Slaughter's picture
This High-Yielder's Wide Moat Is Practically Guaranteed By The Government

This under-the-radar company has the potential to become your portfolio's next market-crusher.

by Nathan Slaughter | January 11, 2017
Richard Saintvilus's picture
Chase This Technology Stock At Your Own Risk

With short sellers circling and waiting to punish the stock, significant price moves are going to get incrementally tougher to come by.

by Richard Saintvilus | January 09, 2017
David Goodboy's picture
A Winning Pharmaceutical Stock For 2017

Severe investor overreaction to one product-line suspension has created a tremendous buying opportunity.

by David Goodboy | January 06, 2017